CCL2 and pancreatic neoplasm: Monti et al. [44] also showed that pancreatic cancer patients with high circulating CCL2 have higher numbers of CD68+ tumor-infiltrating macrophages, and circulating levels of CCL2 are inversely correlated with Ki-67, a well-established marker of tumor cell proliferation.